Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2001

01-09-2001 | Article

Vascularization pattern of c6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain

Authors: Meric A. Altinoz, Engin Ozar, Murat Taskin, Evin Bozcali, Ayhan Bilir, Tuncay Altug, Adnan Aydiner, Aydin Sav

Published in: Pathology & Oncology Research | Issue 3/2001

Login to get access
Metadata
Title
Vascularization pattern of c6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain
Authors
Meric A. Altinoz
Engin Ozar
Murat Taskin
Evin Bozcali
Ayhan Bilir
Tuncay Altug
Adnan Aydiner
Aydin Sav
Publication date
01-09-2001
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2001
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF03032347

Other articles of this Issue 3/2001

Pathology & Oncology Research 3/2001 Go to the issue

Article

Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: Is it helpful?

Review

Telomerase: Biological function and potential role in cancer management

Article

Effect of Earthworm (G-90) Extract on Formation and Lysis of Clots Originated from Venous Blood of Dogs with Cardiopathies and with Malignant Tumors

Article

Alterations in MDM2 expression in esophageal squamous cell carcinoma: Relationship with p53 status

Article

Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer

Article

Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits